Compile Data Set for Download or QSAR

Found 1402 hits with Last Name = 'miura' and Initial = 't'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Plasmepsin II (Plasmodium falciparum)	BDBM50323472 ((R)-3-((2S,3S)-3-(2-(4-((2-aminoethyl)(ethyl)amino...) Show SMILES CCN(CCN)c1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C39H51N5O6S/c1-6-43(17-16-40)28-18-24(2)35(25(3)19-28)50-22-32(46)41-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(4,5)36(44)37(48)42-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,45,47H,6,16-17,20-23,40H2,1-5H3,(H,41,46)(H,42,48)/t30-,31+,33-,34-,36+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid PDB UniChem Similars	PDB Article PubMed	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair				3D Structure (crystal)
Plasmepsin II (Plasmodium falciparum)	BDBM50323469 ((R)-3-((2S,3S)-3-(2-(4-((2-(dimethylamino)ethyl)(m...) Show SMILES CN(C)CCN(C)c1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C40H53N5O6S/c1-25-19-29(44(7)18-17-43(5)6)20-26(2)36(25)51-23-33(47)41-31(21-27-13-9-8-10-14-27)35(48)39(50)45-24-52-40(3,4)37(45)38(49)42-34-30-16-12-11-15-28(30)22-32(34)46/h8-16,19-20,31-32,34-35,37,46,48H,17-18,21-24H2,1-7H3,(H,41,47)(H,42,49)/t31-,32+,34-,35-,37+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid PDB UniChem Similars	PDB Article PubMed	0.100	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair				3D Structure (crystal)
Plasmepsin II (Plasmodium falciparum)	BDBM50209559 ((4R)-3-[(2S,3S)-3-{[(2,6-dimethylphenoxy)acetyl]am...) Show SMILES Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C35H41N3O6S/c1-21-11-10-12-22(2)31(21)44-19-28(40)36-26(17-23-13-6-5-7-14-23)30(41)34(43)38-20-45-35(3,4)32(38)33(42)37-29-25-16-9-8-15-24(25)18-27(29)39/h5-16,26-27,29-30,32,39,41H,17-20H2,1-4H3,(H,36,40)(H,37,42)/t26-,27+,29-,30-,32+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL MMDB PC cid PC sid PDB UniChem Similars	Article PubMed	0.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323470 ((R)-3-((2S,3S)-3-(2-(4-(2-(ethylamino)ethylamino)-...) Show SMILES CCNCCNc1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C39H51N5O6S/c1-6-40-16-17-41-28-18-24(2)35(25(3)19-28)50-22-32(46)42-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(4,5)36(44)37(48)43-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,40-41,45,47H,6,16-17,20-23H2,1-5H3,(H,42,46)(H,43,48)/t30-,31+,33-,34-,36+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	0.680	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001073 (CHEMBL3236067) Show SMILES Cc1cc(NC(=O)CCCCN)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C40H51N5O7S/c1-24-18-28(42-32(47)16-10-11-17-41)19-25(2)36(24)52-22-33(48)43-30(20-26-12-6-5-7-13-26)35(49)39(51)45-23-53-40(3,4)37(45)38(50)44-34-29-15-9-8-14-27(29)21-31(34)46/h5-9,12-15,18-19,30-31,34-35,37,46,49H,10-11,16-17,20-23,41H2,1-4H3,(H,42,47)(H,43,48)(H,44,50)/t30-,31+,34-,35-,37+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001072 (CHEMBL3236066) Show SMILES Cc1cc(NC(=O)CCCN)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C39H49N5O7S/c1-23-17-27(41-31(46)15-10-16-40)18-24(2)35(23)51-21-32(47)42-29(19-25-11-6-5-7-12-25)34(48)38(50)44-22-52-39(3,4)36(44)37(49)43-33-28-14-9-8-13-26(28)20-30(33)45/h5-9,11-14,17-18,29-30,33-34,36,45,48H,10,15-16,19-22,40H2,1-4H3,(H,41,46)(H,42,47)(H,43,49)/t29-,30+,33-,34-,36+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323468 ((R)-3-((2S,3S)-3-(2-(2,6-dimethyl-4-(methyl(2-(met...) Show SMILES CNCCN(C)c1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C39H51N5O6S/c1-24-18-28(43(6)17-16-40-5)19-25(2)35(24)50-22-32(46)41-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(3,4)36(44)37(48)42-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,40,45,47H,16-17,20-23H2,1-6H3,(H,41,46)(H,42,48)/t30-,31+,33-,34-,36+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001070 (CHEMBL3236064) Show SMILES Cc1cc(NC(=O)CN)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C37H45N5O7S/c1-21-14-25(39-29(44)18-38)15-22(2)33(21)49-19-30(45)40-27(16-23-10-6-5-7-11-23)32(46)36(48)42-20-50-37(3,4)34(42)35(47)41-31-26-13-9-8-12-24(26)17-28(31)43/h5-15,27-28,31-32,34,43,46H,16-20,38H2,1-4H3,(H,39,44)(H,40,45)(H,41,47)/t27-,28+,31-,32-,34+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001069 (CHEMBL3236063) Show SMILES Cc1cc(NCc2ccnc3ccccc23)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C45H49N5O6S/c1-27-20-32(47-24-31-18-19-46-35-17-11-10-15-33(31)35)21-28(2)41(27)56-25-38(52)48-36(22-29-12-6-5-7-13-29)40(53)44(55)50-26-57-45(3,4)42(50)43(54)49-39-34-16-9-8-14-30(34)23-37(39)51/h5-21,36-37,39-40,42,47,51,53H,22-26H2,1-4H3,(H,48,52)(H,49,54)/t36-,37+,39-,40-,42+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	1.70	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001071 (CHEMBL3236065) Show SMILES Cc1cc(NC(=O)CCN)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C38H47N5O7S/c1-22-16-26(40-30(45)14-15-39)17-23(2)34(22)50-20-31(46)41-28(18-24-10-6-5-7-11-24)33(47)37(49)43-21-51-38(3,4)35(43)36(48)42-32-27-13-9-8-12-25(27)19-29(32)44/h5-13,16-17,28-29,32-33,35,44,47H,14-15,18-21,39H2,1-4H3,(H,40,45)(H,41,46)(H,42,48)/t28-,29+,32-,33-,35+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	2.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323473 ((R)-3-((2S,3S)-3-(2-(4-(ethyl(2-(ethylamino)ethyl)...) Show SMILES CCNCCN(CC)c1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C41H55N5O6S/c1-7-42-18-19-45(8-2)30-20-26(3)37(27(4)21-30)52-24-34(48)43-32(22-28-14-10-9-11-15-28)36(49)40(51)46-25-53-41(5,6)38(46)39(50)44-35-31-17-13-12-16-29(31)23-33(35)47/h9-17,20-21,32-33,35-36,38,42,47,49H,7-8,18-19,22-25H2,1-6H3,(H,43,48)(H,44,50)/t32-,33+,35-,36-,38+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4.20	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001075 (CHEMBL3236069) Show SMILES Cc1cc(NC(=O)CN2CCOCC2)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C41H51N5O8S/c1-25-18-29(42-33(48)22-45-14-16-53-17-15-45)19-26(2)37(25)54-23-34(49)43-31(20-27-10-6-5-7-11-27)36(50)40(52)46-24-55-41(3,4)38(46)39(51)44-35-30-13-9-8-12-28(30)21-32(35)47/h5-13,18-19,31-32,35-36,38,47,50H,14-17,20-24H2,1-4H3,(H,42,48)(H,43,49)(H,44,51)/t31-,32+,35-,36-,38+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4.30	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001067 (CHEMBL3236061) Show SMILES Cc1cccc(CNc2cc(C)c(OCC(=O)N[C@@H](Cc3ccccc3)[C@H](O)C(=O)N3CSC(C)(C)[C@H]3C(=O)N[C@@H]3[C@H](O)Cc4ccccc34)c(C)c2)n1 |r| Show InChI InChI=1S/C42H49N5O6S/c1-25-18-31(43-22-30-16-11-12-27(3)44-30)19-26(2)38(25)53-23-35(49)45-33(20-28-13-7-6-8-14-28)37(50)41(52)47-24-54-42(4,5)39(47)40(51)46-36-32-17-10-9-15-29(32)21-34(36)48/h6-19,33-34,36-37,39,43,48,50H,20-24H2,1-5H3,(H,45,49)(H,46,51)/t33-,34+,36-,37-,39+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4.40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001068 (CHEMBL3236062) Show SMILES Cc1cc(NCc2c[nH]cn2)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C39H46N6O6S/c1-23-14-27(41-19-28-18-40-21-42-28)15-24(2)35(23)51-20-32(47)43-30(16-25-10-6-5-7-11-25)34(48)38(50)45-22-52-39(3,4)36(45)37(49)44-33-29-13-9-8-12-26(29)17-31(33)46/h5-15,18,21,30-31,33-34,36,41,46,48H,16-17,19-20,22H2,1-4H3,(H,40,42)(H,43,47)(H,44,49)/t30-,31+,33-,34-,36+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	4.80	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323471 ((R)-3-((2S,3S)-3-(2-(4-(2-(diethylamino)ethylamino...) Show SMILES CCN(CC)CCNc1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C41H55N5O6S/c1-7-45(8-2)19-18-42-30-20-26(3)37(27(4)21-30)52-24-34(48)43-32(22-28-14-10-9-11-15-28)36(49)40(51)46-25-53-41(5,6)38(46)39(50)44-35-31-17-13-12-16-29(31)23-33(35)47/h9-17,20-21,32-33,35-36,38,42,47,49H,7-8,18-19,22-25H2,1-6H3,(H,43,48)(H,44,50)/t32-,33+,35-,36-,38+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	5.10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001064 (CHEMBL3236058) Show SMILES Cc1cc(NCCCl)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C37H45ClN4O6S/c1-22-16-26(39-15-14-38)17-23(2)33(22)48-20-30(44)40-28(18-24-10-6-5-7-11-24)32(45)36(47)42-21-49-37(3,4)34(42)35(46)41-31-27-13-9-8-12-25(27)19-29(31)43/h5-13,16-17,28-29,31-32,34,39,43,45H,14-15,18-21H2,1-4H3,(H,40,44)(H,41,46)/t28-,29+,31-,32-,34+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	5.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001074 (CHEMBL3236068) Show SMILES Cc1cc(NC(=O)CCCCCN)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C41H53N5O7S/c1-25-19-29(43-33(48)17-9-6-12-18-42)20-26(2)37(25)53-23-34(49)44-31(21-27-13-7-5-8-14-27)36(50)40(52)46-24-54-41(3,4)38(46)39(51)45-35-30-16-11-10-15-28(30)22-32(35)47/h5,7-8,10-11,13-16,19-20,31-32,35-36,38,47,50H,6,9,12,17-18,21-24,42H2,1-4H3,(H,43,48)(H,44,49)(H,45,51)/t31-,32+,35-,36-,38+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	5.70	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323464 ((R)-3-((2S,3S)-3-(2-(4-(2-aminoethylamino)-2,6-dim...) Show SMILES Cc1cc(NCCN)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C37H47N5O6S/c1-22-16-26(39-15-14-38)17-23(2)33(22)48-20-30(44)40-28(18-24-10-6-5-7-11-24)32(45)36(47)42-21-49-37(3,4)34(42)35(46)41-31-27-13-9-8-12-25(27)19-29(31)43/h5-13,16-17,28-29,31-32,34,39,43,45H,14-15,18-21,38H2,1-4H3,(H,40,44)(H,41,46)/t28-,29+,31-,32-,34+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	6.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323467 ((R)-3-((2S,3S)-3-(2-(4-((2-aminoethyl)(methyl)amin...) Show SMILES CN(CCN)c1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C38H49N5O6S/c1-23-17-27(42(5)16-15-39)18-24(2)34(23)49-21-31(45)40-29(19-25-11-7-6-8-12-25)33(46)37(48)43-22-50-38(3,4)35(43)36(47)41-32-28-14-10-9-13-26(28)20-30(32)44/h6-14,17-18,29-30,32-33,35,44,46H,15-16,19-22,39H2,1-5H3,(H,40,45)(H,41,47)/t29-,30+,32-,33-,35+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	8.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323465 ((R)-3-((2S,3S)-3-(2-(2,6-dimethyl-4-(2-(methylamin...) Show SMILES CNCCNc1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C38H49N5O6S/c1-23-17-27(40-16-15-39-5)18-24(2)34(23)49-21-31(45)41-29(19-25-11-7-6-8-12-25)33(46)37(48)43-22-50-38(3,4)35(43)36(47)42-32-28-14-10-9-13-26(28)20-30(32)44/h6-14,17-18,29-30,32-33,35,39-40,44,46H,15-16,19-22H2,1-5H3,(H,41,45)(H,42,47)/t29-,30+,32-,33-,35+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	9.10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50273749 ((R)-3-((2S,3S)-3-(2-(2,6-dimethyl-4-(pyridin-2-ylm...) Show SMILES Cc1cc(NCc2ccccn2)cc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)C(=O)N1CSC(C)(C)[C@H]1C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |r| Show InChI InChI=1S/C41H47N5O6S/c1-25-18-30(43-22-29-15-10-11-17-42-29)19-26(2)37(25)52-23-34(48)44-32(20-27-12-6-5-7-13-27)36(49)40(51)46-24-53-41(3,4)38(46)39(50)45-35-31-16-9-8-14-28(31)21-33(35)47/h5-19,32-33,35-36,38,43,47,49H,20-24H2,1-4H3,(H,44,48)(H,45,50)/t32-,33+,35-,36-,38+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323474 ((R)-3-((2S,3S)-3-(2-(4-((2-(diethylamino)ethyl)(et...) Show SMILES CCN(CC)CCN(CC)c1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C43H59N5O6S/c1-8-46(9-2)20-21-47(10-3)32-22-28(4)39(29(5)23-32)54-26-36(50)44-34(24-30-16-12-11-13-17-30)38(51)42(53)48-27-55-43(6,7)40(48)41(52)45-37-33-19-15-14-18-31(33)25-35(37)49/h11-19,22-23,34-35,37-38,40,49,51H,8-10,20-21,24-27H2,1-7H3,(H,44,50)(H,45,52)/t34-,35+,37-,38-,40+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	10	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001065 (CHEMBL3236059) Show SMILES COC(CNc1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1)OC |r| Show InChI InChI=1S/C39H50N4O8S/c1-23-16-27(40-20-32(49-5)50-6)17-24(2)35(23)51-21-31(45)41-29(18-25-12-8-7-9-13-25)34(46)38(48)43-22-52-39(3,4)36(43)37(47)42-33-28-15-11-10-14-26(28)19-30(33)44/h7-17,29-30,32-34,36,40,44,46H,18-22H2,1-6H3,(H,41,45)(H,42,47)/t29-,30+,33-,34-,36+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	11	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50323466 ((R)-3-((2S,3S)-3-(2-(4-(2-(dimethylamino)ethylamin...) Show SMILES CN(C)CCNc1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1 |r| Show InChI InChI=1S/C39H51N5O6S/c1-24-18-28(40-16-17-43(5)6)19-25(2)35(24)50-22-32(46)41-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(3,4)36(44)37(48)42-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,40,45,47H,16-17,20-23H2,1-6H3,(H,41,46)(H,42,48)/t30-,31+,33-,34-,36+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	17	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 20: 4836-9 (2010) Article DOI: 10.1016/j.bmcl.2010.06.099 BindingDB Entry DOI: 10.7270/Q2F18ZXQ
					More data for this Ligand-Target Pair
Plasmepsin II (Plasmodium falciparum)	BDBM50001066 (CHEMBL3236060) Show SMILES CCOP(=O)(CCNc1cc(C)c(OCC(=O)N[C@@H](Cc2ccccc2)[C@H](O)C(=O)N2CSC(C)(C)[C@H]2C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c(C)c1)OCC |r| Show InChI InChI=1S/C41H55N4O9PS/c1-7-53-55(51,54-8-2)19-18-42-30-20-26(3)37(27(4)21-30)52-24-34(47)43-32(22-28-14-10-9-11-15-28)36(48)40(50)45-25-56-41(5,6)38(45)39(49)44-35-31-17-13-12-16-29(31)23-33(35)46/h9-17,20-21,32-33,35-36,38,42,46,48H,7-8,18-19,22-25H2,1-6H3,(H,43,47)(H,44,49)/t32-,33+,35-,36-,38+/m0/s1	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	22	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Kyoto Pharmaceutical University Curated by ChEMBL					Assay Description Inhibition of Plasmodium falciparum plasmepsin 2				Bioorg Med Chem Lett 24: 1698-701 (2014) Article DOI: 10.1016/j.bmcl.2014.02.051 BindingDB Entry DOI: 10.7270/Q27S7Q8N
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132916 (US8846746, 194) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cccc(c2)C(C)(C)C)n(n1)-c1ccccc1Cl |r| Show InChI InChI=1S/C25H27ClN4O2/c1-15-18(14-27-23(15)31)24(32)28-22-13-21(16-8-7-9-17(12-16)25(2,3)4)30(29-22)20-11-6-5-10-19(20)26/h5-13,15,18H,14H2,1-4H3,(H,27,31)(H,28,29,32)/t15-,18+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	0.700	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132862 (US8846746, 132) Show SMILES CC(C)(C)c1cccc(c1)-c1cc(NC(=O)[C@H]2CNC(=O)C2)nn1-c1ccccc1Cl |r| Show InChI InChI=1S/C24H25ClN4O2/c1-24(2,3)17-8-6-7-15(11-17)20-13-21(27-23(31)16-12-22(30)26-14-16)28-29(20)19-10-5-4-9-18(19)25/h4-11,13,16H,12,14H2,1-3H3,(H,26,30)(H,27,28,31)/t16-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	0.900	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM493926 (US10988462, Example 37) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cc(F)cc(OC(C)(C)C(F)(F)F)c2)n(n1)-c1cnc(nc1)N(C)C |r| Show InChI InChI=1S/C25H27F4N7O3/c1-13-18(12-30-21(13)37)22(38)33-20-9-19(36(34-20)16-10-31-23(32-11-16)35(4)5)14-6-15(26)8-17(7-14)39-24(2,3)25(27,28)29/h6-11,13,18H,12H2,1-5H3,(H,30,37)(H,33,34,38)/t13-,18+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.980	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. US Patent					Assay Description Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...				US Patent US10988462 (2021) BindingDB Entry DOI: 10.7270/Q2TH8QV5
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM109863 (US8609647, 1 | US8609647, 15 | US8609647, 2 | US86...) Show SMILES CC1CN(C(=O)CC#N)C11CCCN(C1)c1ncnc2[nH]ccc12 Show InChI InChI=1S/C17H20N6O/c1-12-9-23(14(24)3-6-18)17(12)5-2-8-22(10-17)16-13-4-7-19-15(13)20-11-21-16/h4,7,11-12H,2-3,5,8-10H2,1H3,(H,19,20,21)	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. US Patent					Assay Description In the kinase reactions, fused proteins (6His tag-fused hJAK2 kinase domain (aa808-end)) which were coexpressed in Sf21 cells and purified by Ni2+/NT...				US Patent US8609647 (2013) BindingDB Entry DOI: 10.7270/Q29C6W24
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132870 (US8846746, 140) Show SMILES CCC(F)(F)c1cccc(c1)-c1cc(NC(=O)[C@H]2CNC(=O)C2)nn1-c1ccccc1Cl |r| Show InChI InChI=1S/C23H21ClF2N4O2/c1-2-23(25,26)16-7-5-6-14(10-16)19-12-20(28-22(32)15-11-21(31)27-13-15)29-30(19)18-9-4-3-8-17(18)24/h3-10,12,15H,2,11,13H2,1H3,(H,27,31)(H,28,29,32)/t15-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM133145 (US8846746, 463) Show SMILES CCOc1ccc(F)c(c1)-n1nc(NC(=O)[C@@H]2CNC(=O)C2)cc1-c1cccc(CO[C@H](C)C(F)(F)F)c1 |r| Show InChI InChI=1S/C26H26F4N4O4/c1-3-37-19-7-8-20(27)22(11-19)34-21(12-23(33-34)32-25(36)18-10-24(35)31-13-18)17-6-4-5-16(9-17)14-38-15(2)26(28,29)30/h4-9,11-12,15,18H,3,10,13-14H2,1-2H3,(H,31,35)(H,32,33,36)/t15-,18+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132882 (US8846746, 154) Show SMILES CCC(F)(F)c1cccc(c1)-c1cc(NC(=O)[C@H]2CNC(=O)[C@@H]2C)nn1-c1ccccc1 |r| Show InChI InChI=1S/C24H24F2N4O2/c1-3-24(25,26)17-9-7-8-16(12-17)20-13-21(29-30(20)18-10-5-4-6-11-18)28-23(32)19-14-27-22(31)15(19)2/h4-13,15,19H,3,14H2,1-2H3,(H,27,31)(H,28,29,32)/t15-,19+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM50193995 (3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr...) Show SMILES C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N |r| Show InChI InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL DrugBank MCE MMDB PC cid PC sid PDB UniChem Patents Similars	Article PubMed	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. Curated by ChEMBL					Assay Description Inhibition of human JAK3 (780 to end residues) expressed in baculovirus infected Sf9 cells using TK-substrate-biotin as substrate incubated for 60 mi...				J Med Chem 63: 7163-7185 (2020) Article DOI: 10.1021/acs.jmedchem.0c00450 BindingDB Entry DOI: 10.7270/Q2FX7F2W
					More data for this Ligand-Target Pair
A disintegrin and metalloproteinase with thrombospondin motifs 4 (Homo sapiens (Human))	BDBM50167609 ((2R,5R)-1-[4-(2,4-Dichloro-benzyloxy)-benzenesulfo...) Show SMILES CC1(C)C[C@@H](O)CN([C@H]1C(=O)NO)S(=O)(=O)c1ccc(OCc2ccc(Cl)cc2Cl)cc1 Show InChI InChI=1S/C21H24Cl2N2O6S/c1-21(2)10-15(26)11-25(19(21)20(27)24-28)32(29,30)17-7-5-16(6-8-17)31-12-13-3-4-14(22)9-18(13)23/h3-9,15,19,26,28H,10-12H2,1-2H3,(H,24,27)/t15-,19+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
Central Pharmaceutical Research Institute Curated by ChEMBL					Assay Description Inhibition of human recombinant aggrecanase 1 after 150 mins by fluorescence plate reader				J Med Chem 54: 2839-63 (2011) Article DOI: 10.1021/jm101609j BindingDB Entry DOI: 10.7270/Q2N87B3D
					More data for this Ligand-Target Pair
Matrix metalloproteinase-14 (Homo sapiens (Human))	BDBM50341824 ((1S,2R,3R)-2-Methyl-1-[5-(4-methylpyrazol-1-yl)thi...) Show SMILES C[C@@H]1[C@H](c2ccccc2)[C@]1(NS(=O)(=O)c1ccc(s1)-n1cc(C)cn1)C(O)=O |r| Show InChI InChI=1S/C19H19N3O4S2/c1-12-10-20-22(11-12)15-8-9-16(27-15)28(25,26)21-19(18(23)24)13(2)17(19)14-6-4-3-5-7-14/h3-11,13,17,21H,1-2H3,(H,23,24)/t13-,17-,19+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Central Pharmaceutical Research Institute Curated by ChEMBL					Assay Description Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader				J Med Chem 54: 2839-63 (2011) Article DOI: 10.1021/jm101609j BindingDB Entry DOI: 10.7270/Q2N87B3D
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM493894 (US10988462, Example 10) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cc(F)cc(OC(C)(C)C(F)(F)F)c2)n(n1)-c1cncc(c1)C(F)(F)F |r| Show InChI InChI=1S/C25H22F7N5O3/c1-12-18(11-34-21(12)38)22(39)35-20-8-19(37(36-20)16-6-14(9-33-10-16)24(27,28)29)13-4-15(26)7-17(5-13)40-23(2,3)25(30,31)32/h4-10,12,18H,11H2,1-3H3,(H,34,38)(H,35,36,39)/t12-,18+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. US Patent					Assay Description Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...				US Patent US10988462 (2021) BindingDB Entry DOI: 10.7270/Q2TH8QV5
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM50193995 (3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr...) Show SMILES C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N |r| Show InChI InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL DrugBank MCE MMDB PC cid PC sid PDB UniChem Patents Similars	PDB Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. Curated by ChEMBL					Assay Description Inhibition of N-terminal GST-fused human JAK2 (880 to end residues) expressed in baculovirus infected Sf21 cells using TK-substrate-biotin as substra...				J Med Chem 63: 7163-7185 (2020) Article DOI: 10.1021/acs.jmedchem.0c00450 BindingDB Entry DOI: 10.7270/Q2FX7F2W
					More data for this Ligand-Target Pair				3D Structure (crystal)
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132856 (US8846746, 126) Show SMILES CC(C)(C)c1cccc(c1)-c1cc(NC(=O)[C@H]2CNC(=O)C2)nn1-c1cccc(Cl)c1 |r| Show InChI InChI=1S/C24H25ClN4O2/c1-24(2,3)17-7-4-6-15(10-17)20-13-21(27-23(31)16-11-22(30)26-14-16)28-29(20)19-9-5-8-18(25)12-19/h4-10,12-13,16H,11,14H2,1-3H3,(H,26,30)(H,27,28,31)/t16-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM493906 (US10988462, Example 21) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cc(F)cc(OC(C)(C)C(F)(F)F)c2)n(n1)-c1cncc(F)c1 |r| Show InChI InChI=1S/C24H22F5N5O3/c1-12-18(11-31-21(12)35)22(36)32-20-8-19(34(33-20)16-6-15(26)9-30-10-16)13-4-14(25)7-17(5-13)37-23(2,3)24(27,28)29/h4-10,12,18H,11H2,1-3H3,(H,31,35)(H,32,33,36)/t12-,18+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. US Patent					Assay Description Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...				US Patent US10988462 (2021) BindingDB Entry DOI: 10.7270/Q2TH8QV5
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM493905 (US10988462, Example 20) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cc(F)cc(OC(C)(C)C(F)(F)F)c2)n(n1)-c1ccc(nc1)C(F)(F)F |r| Show InChI InChI=1S/C25H22F7N5O3/c1-12-17(11-34-21(12)38)22(39)35-20-9-18(37(36-20)15-4-5-19(33-10-15)24(27,28)29)13-6-14(26)8-16(7-13)40-23(2,3)25(30,31)32/h4-10,12,17H,11H2,1-3H3,(H,34,38)(H,35,36,39)/t12-,17+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. US Patent					Assay Description Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...				US Patent US10988462 (2021) BindingDB Entry DOI: 10.7270/Q2TH8QV5
					More data for this Ligand-Target Pair
Matrix metalloproteinase-14 (Homo sapiens (Human))	BDBM50341816 ((1S,2R,3R)-1-[5-(4-Methoxypyrazol-1-yl)thiophene-2...) Show SMILES COc1cnn(c1)-c1ccc(s1)S(=O)(=O)N[C@]1([C@H](C)[C@@H]1c1ccccc1)C(O)=O |r| Show InChI InChI=1S/C19H19N3O5S2/c1-12-17(13-6-4-3-5-7-13)19(12,18(23)24)21-29(25,26)16-9-8-15(28-16)22-11-14(27-2)10-20-22/h3-12,17,21H,1-2H3,(H,23,24)/t12-,17-,19+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Central Pharmaceutical Research Institute Curated by ChEMBL					Assay Description Inhibition of human recombinant MMP14 after 60 mins by fluorescence plate reader				J Med Chem 54: 2839-63 (2011) Article DOI: 10.1021/jm101609j BindingDB Entry DOI: 10.7270/Q2N87B3D
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132860 (US8846746, 130) Show SMILES FC(F)(F)Oc1cccc(c1)-c1cc(NC(=O)[C@H]2CNC(=O)C2)nn1-c1ccccc1Cl |r| Show InChI InChI=1S/C21H16ClF3N4O3/c22-15-6-1-2-7-16(15)29-17(12-4-3-5-14(8-12)32-21(23,24)25)10-18(28-29)27-20(31)13-9-19(30)26-11-13/h1-8,10,13H,9,11H2,(H,26,30)(H,27,28,31)/t13-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM493901 (US10988462, Example 17) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cc(F)cc(OC(C)(C)C(F)(F)F)c2)n(n1)-c1cncc(Cl)c1 |r| Show InChI InChI=1S/C24H22ClF4N5O3/c1-12-18(11-31-21(12)35)22(36)32-20-8-19(34(33-20)16-6-14(25)9-30-10-16)13-4-15(26)7-17(5-13)37-23(2,3)24(27,28)29/h4-10,12,18H,11H2,1-3H3,(H,31,35)(H,32,33,36)/t12-,18+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	n/a
Japan Tobacco Inc. US Patent					Assay Description Human SGLT1-stably-expressing cell lines were seeded at 5×104 cells/well on BioCoat™ Poly-D-Lysine 96 well plate with Lid (Becton, Dickinson and Comp...				US Patent US10988462 (2021) BindingDB Entry DOI: 10.7270/Q2TH8QV5
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132929 (US8846746, 208) Show SMILES CCC(F)(F)c1cccc(c1)-c1cc(NC(=O)[C@H]2CNC(=O)[C@@H]2C)nn1-c1ccccc1Cl |r| Show InChI InChI=1S/C24H23ClF2N4O2/c1-3-24(26,27)16-8-6-7-15(11-16)20-12-21(29-23(33)17-13-28-22(32)14(17)2)30-31(20)19-10-5-4-9-18(19)25/h4-12,14,17H,3,13H2,1-2H3,(H,28,32)(H,29,30,33)/t14-,17+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132915 (US8846746, 193) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cccc(OC(F)(F)F)c2)n(n1)-c1ccccc1Cl |r| Show InChI InChI=1S/C22H18ClF3N4O3/c1-12-15(11-27-20(12)31)21(32)28-19-10-18(30(29-19)17-8-3-2-7-16(17)23)13-5-4-6-14(9-13)33-22(24,25)26/h2-10,12,15H,11H2,1H3,(H,27,31)(H,28,29,32)/t12-,15+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132874 (US8846746, 144) Show SMILES CCC(F)(F)c1cccc(c1)-c1cc(NC(=O)[C@H]2CNC(=O)C2)nn1-c1ccccc1C |r| Show InChI InChI=1S/C24H24F2N4O2/c1-3-24(25,26)18-9-6-8-16(11-18)20-13-21(28-23(32)17-12-22(31)27-14-17)29-30(20)19-10-5-4-7-15(19)2/h4-11,13,17H,3,12,14H2,1-2H3,(H,27,31)(H,28,29,32)/t17-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.30	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM133143 (US8846746, 461) Show SMILES CC(C)Oc1ccc(F)c(c1)-n1nc(NC(=O)[C@@H]2CNC(=O)C2)cc1-c1cccc(COCC(F)(F)F)c1 |r| Show InChI InChI=1S/C26H26F4N4O4/c1-15(2)38-19-6-7-20(27)22(10-19)34-21(11-23(33-34)32-25(36)18-9-24(35)31-12-18)17-5-3-4-16(8-17)13-37-14-26(28,29)30/h3-8,10-11,15,18H,9,12-14H2,1-2H3,(H,31,35)(H,32,33,36)/t18-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
A disintegrin and metalloproteinase with thrombospondin motifs 5 (Homo sapiens (Human))	BDBM50167609 ((2R,5R)-1-[4-(2,4-Dichloro-benzyloxy)-benzenesulfo...) Show SMILES CC1(C)C[C@@H](O)CN([C@H]1C(=O)NO)S(=O)(=O)c1ccc(OCc2ccc(Cl)cc2Cl)cc1 Show InChI InChI=1S/C21H24Cl2N2O6S/c1-21(2)10-15(26)11-25(19(21)20(27)24-28)32(29,30)17-7-5-16(6-8-17)31-12-13-3-4-14(22)9-18(13)23/h3-9,15,19,26,28H,10-12H2,1-2H3,(H,24,27)/t15-,19+/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
Central Pharmaceutical Research Institute Curated by ChEMBL					Assay Description Inhibition of human recombinant aggrecanase 2 after 150 mins by fluorescence plate reader				J Med Chem 54: 2839-63 (2011) Article DOI: 10.1021/jm101609j BindingDB Entry DOI: 10.7270/Q2N87B3D
					More data for this Ligand-Target Pair
Sodium/glucose cotransporter 1 (Homo sapiens (Human))	BDBM132924 (US8846746, 203) Show SMILES C[C@@H]1[C@H](CNC1=O)C(=O)Nc1cc(-c2cccc(c2)C(F)(F)F)n(n1)-c1ccccc1Cl |r| Show InChI InChI=1S/C22H18ClF3N4O2/c1-12-15(11-27-20(12)31)21(32)28-19-10-18(13-5-4-6-14(9-13)22(24,25)26)30(29-19)17-8-3-2-7-16(17)23/h2-10,12,15H,11H2,1H3,(H,27,31)(H,28,29,32)/t12-,15+/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	37
Japan Tobacco Inc. US Patent					Assay Description The stable cell line expressing human SGLT1 was seeded at 5x104 cells/well on BioCoat Poly-D-Lysine 96 well plate with Lid (Becton Dickinson and Comp...				US Patent US8846746 (2014) BindingDB Entry DOI: 10.7270/Q27M06MJ
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50288232 (2-[2-(carboxymethoxy)-4-(2-{4H,5H,6H,7H-thieno[2,3...) Show SMILES OC(=O)COc1ccc(cc1OCC(O)=O)C(=O)CNC(=O)c1cc2CCNCc2s1 Show InChI InChI=1S/C20H20N2O8S/c23-13(7-22-20(28)16-6-12-3-4-21-8-17(12)31-16)11-1-2-14(29-9-18(24)25)15(5-11)30-10-19(26)27/h1-2,5-6,21H,3-4,7-10H2,(H,22,28)(H,24,25)(H,26,27)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article	n/a	n/a	1.40	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Inhibition of Vitronectin binding to GPIIb/IIIIa Vitronectin receptor				Bioorg Med Chem Lett 6: 2601-2606 (1996) Article DOI: 10.1016/0960-894X(96)00476-3 BindingDB Entry DOI: 10.7270/Q28C9W76
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 1402 total )  |  Next  |  Last  >>

Jump to: